Raymond James sees scope for modest upside when a major medical technology (MedTech) group reports third-quarter earnings, pointing to steady ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE